Lehrstuhl für Geburtshilfe und Frauenheilkunde

Fully automatic HER2 tissue segmentation for interpretable HER2 scoring (2025) Öttl M, Steenpaß J, Wilm F, Qiu J, Rübner M, Lang-Schwarz C, Taverna C, et al. Journal article Improving quality of care for cancer patients through oncological second opinions in a Comprehensive Cancer Center: adherence to second-opinion therapy recommendations (2025) Schulmeyer C, Fasching P, Beckmann M, Häberle L, Golcher H, Goebell P, Pöschke P, Emons J Journal article Correction to: Evaluation of endocervical curettage (ECC) in colposcopy for detecting cervical intraepithelial lesions (Archives of Gynecology and Obstetrics, (2024), 310, 6, (3037-3045), 10.1007/s00404-024-07721-w) (2025) Behrens A, Dietl A, Adler W, Geppert CI, Hartmann A, Knöll A, Beckmann M, et al. Journal article, Erratum RAD51 Testing in Patients with Early HER2-Negative Breast Cancer and Homologous Recombination Deficiency: A Post Hoc Analysis of the GeparOLA Trial (2025) Villacampa G, Llop-Guevara A, Filmann N, Herencia-Ropero A, Fasching P, Karn T, Marmé F, et al. Journal article Cell-free tumor DNA analysis in advanced or metastatic breast cancer patients: mutation frequencies, testing intention, and clinical impact (2025) Hübner H, Wimberger P, Laakmann E, Ruckhäberle E, Rübner M, Lehle S, Uhrig S, et al. Journal article A Swedish genome-wide haplotype association analysis identifies novel candidate loci associated with endometrial cancer risk (2025) Barnekow E, Liu W, Andersson E, Wang X, Helgadottir HT, Thutkawkorapin J, Barilla S, et al. Journal article The Role of Artificial Intelligence in Gynecologic Oncology Decision-Making: A Feasibility Study (2025) Psilopatis I, Sipulina N, Stübs F, Heindl F, Pöschke P, Bader S, Krückel A, et al. Journal article Dynamics of molecular heterogeneity in high-risk luminal breast cancer—From intrinsic to adaptive subtyping (2025) Denkert C, Rachakonda S, Karn T, Weber K, Martin M, Marmé F, Untch M, et al. Journal article Low-dose Oral Misoprostol after Cervical Ripening with a Double-balloon Catheter: 25 µg or 50 µg? (2025) Kehl S, Karademir ZS, Weiss C, Titzmann A, Schneider M, Beckmann M, Bader S Journal article A phase III trial of adjuvant ribociclib plus endocrine therapy versus endocrine therapy alone in patients with HR-positive/HER2-negative early breast cancer: final invasive disease-free survival results from the NATALEE trial (2025) Hortobagyi GN, Lacko A, Sohn J, Cruz F, Ruiz Borrego M, Manikhas A, Hee Park Y, et al. Journal article